Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis

NCT00004829 is registered in ClinicalTrials.gov with FDA Office of Orphan Products Development as lead sponsor.

NCT NCT00004829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis
Lead sponsor
FDA Office of Orphan Products Development
Phase
Phase 3
Overall status
Completed
Start date
June 30, 1995
Completion date
May 31, 1998
Enrollment
200
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial infection, cystic fibrosis